ApicHope Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
ApicHope Pharmaceutical has a total shareholder equity of CN¥2.5B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 48.1%. Its total assets and total liabilities are CN¥4.5B and CN¥2.0B respectively. ApicHope Pharmaceutical's EBIT is CN¥112.3M making its interest coverage ratio 3.4. It has cash and short-term investments of CN¥649.6M.
Key information
48.1%
Debt to equity ratio
CN¥1.22b
Debt
| Interest coverage ratio | 3.4x |
| Cash | CN¥649.62m |
| Equity | CN¥2.53b |
| Total liabilities | CN¥1.97b |
| Total assets | CN¥4.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300723's short term assets (CN¥1.5B) do not cover its short term liabilities (CN¥1.6B).
Long Term Liabilities: 300723's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥392.3M).
Debt to Equity History and Analysis
Debt Level: 300723's net debt to equity ratio (22.5%) is considered satisfactory.
Reducing Debt: 300723's debt to equity ratio has increased from 3.8% to 48.1% over the past 5 years.
Debt Coverage: 300723's debt is well covered by operating cash flow (35.9%).
Interest Coverage: 300723's interest payments on its debt are well covered by EBIT (3.4x coverage).